,outcome,arm 1,arm 2,comparative statistic,95% CI,p-value,note
0,intervention,risperidone group,,,,,
0,"Increased appetite, dizziness, drooling, drowsiness, fatigue",more common,NR,NR,NR,P<0.05,NR
